EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

A protocol for high-throughput screening for immunomodulatory compounds using human primary cells

Katherine Chew, Branden Lee, Al Ozonoff, Jennifer A Smith, Ofer Levy, David J Dowling, Simon Van Haren

STAR Protocols · 2023

DOI: 10.1016/j.xpro.2023.102405 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2023. Verfasst von Katherine Chew und 6 weiteren Autor:innen. Beteiligte Einrichtung: Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Immunomodulating Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-throughput screening is a powerful platform that can rapidly provide valuable cytotoxic, immunological, and phenotypical information for thousands of compounds. Human peripheral blood mononuclear cells (PBMCs) cultured in autologous plasma can model the human immune response. Here, we describe a protocol to stimulate PBMCs for 72 h and measure cytokine secretion via AlphaLISA assays and cell surface activation marker expression via flow cytometry. Cryopreserved PBMCs are incubated for 72 h with various small molecule libraries and the supernatants are harvested to rapidly measure secretion levels of key cytokines (tumor necrosis factor alpha, interferon gamma, interleukin 10) via the AlphaLISA assay. Almost simultaneously, the cells can be fixated and stained using antibodies against innate immune activation markers (CD80, CD86, HLA-DR, OX40) for analysis via flow cytometry. This multiplexed readout workflow can directly aid in the phenotypic identification and discovery of novel immunomodulators and potential vaccine adjuvant candidates. For complete details on the use and execution of this protocol, please refer to Chew et al.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocytes, MononuclearImmunomodulating AgentsHumansHigh-Throughput Screening AssaysCytokinesTumor Necrosis Factor-alphaBiomarkers

Stichwörter der Autor:innen

Biotechnology and bioengineeringCell-based AssaysFlow Cytometry/Mass CytometryHigh-Throughput ScreeningImmunology

Substanzen

Immunomodulating AgentsCytokinesTumor Necrosis Factor-alphaBiomarkers

Autor:innen und Institutionen

  • Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
  • Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • ICCB-Longwood Screening Facility, Harvard Medical School, Boston, MA, USA.
  • Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT & Harvard, Cambridge, M…
  • Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. Electronic address: david.dowling@childrens.ha…
  • Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. Electronic address: simon.vanharen@childrens.h…

Zitieren

APA

Chew, K., Lee, B., Ozonoff, A., Smith, J. A., Levy, O., Dowling, D. J., & Van Haren, S. (2023). A protocol for high-throughput screening for immunomodulatory compounds using human primary cells. STAR Protocols. https://doi.org/10.1016/j.xpro.2023.102405

Vancouver

Chew K, Lee B, Ozonoff A, Smith JA, Levy O, Dowling DJ, et al. A protocol for high-throughput screening for immunomodulatory compounds using human primary cells. STAR Protocols. 2023. doi:10.1016/j.xpro.2023.102405

BibTeX
@article{Chew2023,
  author = {Chew, Katherine and Lee, Branden and Ozonoff, Al and Smith, Jennifer A and Levy, Ofer and Dowling, David J and Van Haren, Simon},
  title = {A protocol for high-throughput screening for immunomodulatory compounds using human primary cells},
  journal = {STAR Protocols},
  year = {2023},
  doi = {10.1016/j.xpro.2023.102405}
}
Kostenlos starten →